Drugs / DC/RCC fusion vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01441765 Comparator | Nov 2011 → Jul 2016 | renal cell carcinoma | Beth Israel Deaconess Medical Center | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC/RCC fusion vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01441765 ↗ |
| Known as | DC RCC Vaccine | “The DC RCC Vaccine is agent that tries to help the immune system to recognize and fight against cancer cells.” NCT01441765 ↗ |
| Modality | Vaccine | “The DC RCC Vaccine is agent that tries to help the immune system to recognize and fight against cancer cells.” NCT01441765 ↗ |